Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C74080
http://purl.obolibrary.org/obo/NCIT_C74080
|
|---|---|
| Preferred Name | Tasquinimod |
| Definitions |
A quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts. |
|---|---|
| prefLabel | Tasquinimod
|
| label | Tasquinimod
|
| PDQ_Closed_Trial_Search_ID | 581229
|
| code | C74080
|
| prefixIRI | NCIT:C74080
|
| in_subset |
See more
See less
|
| Display_Name | Tasquinimod
|
| Preferred_Name | Tasquinimod
|
| FDA_UNII_Code | 756U07KN1R
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C20H17F3N2O4
|
| Maps_To | Tasquinimod
|
| CAS_Registry | 254964-60-8
|
| NCI_Drug_Dictionary_ID | 581229
|
| Legacy Concept Name | Tasquinimod
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 581229
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1956491
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |